Back to Journals » Journal of Asthma and Allergy » Volume 8

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

Total article views   HTML views PDF downloads Totals
22,342 Dovepress* 16,790+ 2,829 19,619
PubMed Central* 5,552 1,636 7,188
Totals 22,342 4,465 26,807
*Since 8 October 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed and Google Scholar